Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.35 USD | +1.96% | -0.43% | -56.55% |
Sales 2024 * | 440M 34.53B | Sales 2025 * | 464M 36.45B | Capitalization | 343M 26.96B |
---|---|---|---|---|---|
Net income 2024 * | -84M -6.59B | Net income 2025 * | -77M -6.04B | EV / Sales 2024 * | 0.57 x |
Net cash position 2024 * | 92.26M 7.24B | Net cash position 2025 * | 81.38M 6.39B | EV / Sales 2025 * | 0.56 x |
P/E ratio 2024 * |
-4.04
x | P/E ratio 2025 * |
-4.46
x | Employees | 1,215 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.14% |
Latest transcript on Nevro Corp.
1 day | +1.96% | ||
1 week | -0.43% | ||
1 month | -10.18% | ||
3 months | -34.25% | ||
6 months | -50.32% | ||
Current year | -56.55% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Thornal
CEO | Chief Executive Officer | 50 | 23/04/23 |
D. Grossman
CHM | Chairman | 63 | 18/03/19 |
Roderick MacLeod
DFI | Director of Finance/CFO | 57 | 14/06/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael DeMane
BRD | Director/Board Member | 67 | 16/03/11 |
Karen Prange
BRD | Director/Board Member | 60 | 16/12/19 |
D. Grossman
CHM | Chairman | 63 | 18/03/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 9.35 | +1.96% | 396,471 |
30/05/24 | 9.17 | -0.86% | 869,593 |
29/05/24 | 9.25 | -2.84% | 487,182 |
28/05/24 | 9.52 | +1.38% | 479,463 |
24/05/24 | 9.39 | -.--% | 431,529 |
Delayed Quote Nyse, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.55% | 343M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- NVRO Stock